Long-read nanopore sequencing-based draft genome of a carbapenem-resistant Pseudomonas aeruginosa isolate

•Genome sequencing of carbapenem-resistant P. aeruginosa using MiSeq short-read and Oxford Nanopore long-read sequencing.•The resulting assembly is highly contiguous, containing a total of 6624003bp with three contigs.•Annotation identified 6389 protein-coding genes, of which 6241 (97.7%) were annot...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of global antimicrobial resistance. 2019-12, Vol.19, p.207-209
Hauptverfasser: Yu, Xiaoling, Han, Zhaofang, Ye, Chengsong, Zhou, Shuyan, Wu, Shaogui, Han, Lifen, Zheng, Ling, Hu, Yiqun, Ye, Hanhui
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Genome sequencing of carbapenem-resistant P. aeruginosa using MiSeq short-read and Oxford Nanopore long-read sequencing.•The resulting assembly is highly contiguous, containing a total of 6624003bp with three contigs.•Annotation identified 6389 protein-coding genes, of which 6241 (97.7%) were annotated in at least one protein database. Pseudomonas aeruginosa is a common Gram-negative bacterium causing various serious infections, such as lower respiratory tract infection and urinary tract infection in catheterised patients. Here we report the draft genome sequence of a carbapenem-resistant P. aeruginosa (CRPA) isolate. The genome of the CRPA isolate was sequenced using a combination of short, highly accurate Illumina reads and additional coverage in very long Oxford Nanopore reads. The resulting assembly was highly contiguous, containing a total of 6624003bp with a GC content of 66.21%. Annotation identified 6389 protein-coding genes. Mutations in the oprD and mexR genes conferred resistance to carbapenems in the CRPA isolate. The draft genome sequence of this CRPA isolate could provide a solid basis for further research on the resistance mechanisms and the development of drug therapy for drug resistance genes.
ISSN:2213-7165
2213-7173
DOI:10.1016/j.jgar.2019.05.023